Videos

An Introduction to Audit Trail Review in Clinical Trials [Video]

Written by Marketing Quanticate | Nov 20, 2026, 5:32:43 PM

 

Audit trail review in clinical trials is the step where someone examines the electronic record of who changed trial data, what changed and when, and decides whether anything needs a closer look. Most changes turn out to be expected, so the work lies in spotting the patterns or single events that need more context. This video explains how to scope audit trail review around risk, when to carry it out, and how to handle what it finds.

WHAT THIS VIDEO COVERS
• The difference between trial-level review of clinical data and system-level review of access, configuration and security activity
• Why reviewing every available audit trail is rarely practical, and how an eligibility criterion shows risk-based scoping
• Checking metadata access, format and responsibilities for external systems during vendor selection and study set-up
• Why a first review at database lock leaves fewer options than review during study conduct
• Sponsor oversight when audit trail work is delegated to a CRO or technology vendor
• Investigating and documenting an anomaly, such as a safety field edited several times

Clear ownership between teams avoids review gaps and duplicated effort. Earlier review leaves time to investigate with the site or change a process. Automated flags and visualisations still need someone who understands the study to interpret them, and metadata limitations such as inconsistent formats or unclear timestamps can restrict what a review can show.